# Long-term memory effects of an incremental blood pressure intervention in a mortal cohort

**Authors:** Maria Josefsson, Nina Karalija, Michael J Daniels

PMC · DOI: 10.1093/biomtc/ujaf176 · Biometrics · 2026-02-03

## TL;DR

This study investigates whether lowering blood pressure over 15 years affects memory, considering both mortality and memory outcomes.

## Contribution

The study introduces a Bayesian semi-parametric estimation approach and a novel sparsity-inducing Dirichlet prior for longitudinal data.

## Key findings

- No significant memory effects were found from the blood pressure intervention.
- The intervention did not strongly affect memory in the overall population or in the always survivor stratum.
- The proposed Bayesian method was validated through simulations and compared to other approaches.

## Abstract

In the present study, we examine long-term population-level effects on episodic memory of an intervention over 15 years that reduces systolic blood pressure in individuals with hypertension. A limitation with previous research on the potential risk reduction of such interventions is that they do not properly account for the reduction of mortality rates. Hence, one can only speculate whether the effect is due to changes in memory or changes in mortality. Therefore, we extend previous research by providing both an etiological and a prognostic effect estimate. To do this, we propose a Bayesian semi-parametric estimation approach for an incremental threshold intervention, using the extended G-formula. Additionally, we introduce a novel sparsity-inducing Dirichlet prior for longitudinal data, that exploits the longitudinal structure of the data. We demonstrate the usefulness of our approach in simulations, and compare its performance to other Bayesian decision tree ensemble approaches. In our analysis of the data from the Betula cohort, we found no significant prognostic or etiological effects across all ages. This suggests that systolic blood pressure interventions likely do not strongly affect memory, either at the overall population level or among individuals who would remain alive under both the natural course and the intervention (the always survivor stratum).

## Full-text entities

- **Genes:** SELENBP1 (selenium binding protein 1) [NCBI Gene 8991] {aka EHMTO, HEL-S-134P, LPSB, MTO, SBP56, SP56}
- **Diseases:** Dementia (MESH:D003704), type 2 diabetes (MESH:D003924), cancer (MESH:D009369), Hypertension (MESH:D006973), memory decline (MESH:D060825), congestive heart failure (MESH:D006333), death (MESH:D003643), cognitive impairment (MESH:D003072), COVID-19 (MESH:D000086382)
- **Chemicals:** cholesterol (MESH:D002784)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12865380/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12865380/full.md

## References

43 references — full list in the complete paper: https://tomesphere.com/paper/PMC12865380/full.md

---
Source: https://tomesphere.com/paper/PMC12865380